Journal article

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from theCardio-OncologyStudyGroup of theHeartFailureAssociation of theEuropeanSociety ofCardiology in collaboration with theInternationalCardio-OncologySociety

Alexander R Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden-Masley, Alain Cohen-Solal, Carlo G Tocchetti, Javid J Moslehi, John D Groarke, Jutta Bergler-Klein, Vincent Khoo, Li Ling Tan, Markus S Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G Neilan Show all

European Journal of Heart Failure | WILEY | Published : 2020

University of Melbourne Researchers

Grants

Awarded by Heart Foundation of Australia Future Leader Fellowship


Awarded by European Research Council


Awarded by Netherlands Heart Foundation


Awarded by Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI)


Awarded by German Research Foundation (DFG)


Awarded by German Ministry of Education and Research (BMBF)



Funding Acknowledgements

A.R.L. is supported by the Fondation Leducq Network of Excellence in Cardio-Oncology. C.G.T. is supported by the grant 'Ricerca di Ateneo Federico II 2017'. A.L.S. is supported by the Heart Foundation of Australia Future Leader Fellowship (Award ID 101918). J.M. is supported by R01 HL141466. R.A.d.B. is supported by the European Research Council (ERC CoG 818715, SECRETE-HF), and furthermore by the Netherlands Heart Foundation (CVON DOSIS, grant 2014-40, CVON SHE-PREDICTS-HF, grant 2017-21; CVON RED-CVD, grant 2017-11; and CVON PREDICT2, grant 2018-30); and the Innovational Research Incentives Scheme program of the Netherlands Organization for Scientific Research (NWO VIDI, grant 917.13.350). C.M. is supported by the German Research Foundation (DFG; SFB-894, TRR-219; Ma 2528/7-1) and the German Ministry of Education and Research (BMBF; 01EO1504). M.S.A. has received research support from the German Cardiovascular Research Center.